These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7317235)
21. [Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)]. Klein W; Goebel R Z Kardiol; 1980 Feb; 69(2):120-5. PubMed ID: 6779433 [No Abstract] [Full Text] [Related]
22. [Short- and medium-term hemodynamic effects of prazosin in chronic refractory cardiac failure]. Gillard C; Boland J; Calay G Arch Mal Coeur Vaiss; 1982 Apr; 75(4):469-77. PubMed ID: 6808956 [TBL] [Abstract][Full Text] [Related]
23. [Effect of prazosin in therapy-resistant chronic cardiac failure (author's transl)]. Lemke R; Trompler A; Kaltenbach M; Bussmann WD Dtsch Med Wochenschr; 1979 Dec; 104(50):1769-73. PubMed ID: 510213 [TBL] [Abstract][Full Text] [Related]
24. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin. Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of prazosin in chronic heart failure. Parmley WW; Chatterjee K; Arnold S; Rubin SA; Brundage BH; Williams RL; Ports T; Chuck L; Rouleau J Am Heart J; 1981 Sep; 102(3 Pt 2):622-5. PubMed ID: 7270404 [TBL] [Abstract][Full Text] [Related]
26. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure. Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582 [TBL] [Abstract][Full Text] [Related]
27. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study. Rouleau JL; Chatterjee K; Benge W; Parmley WW; Hiramatsu B Circulation; 1982 Apr; 65(4):671-8. PubMed ID: 7037220 [No Abstract] [Full Text] [Related]
28. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year]. Reifart N; Schmidt-Moritz AD; Nadj M; Kaltenbach M; Bussmann WD Z Kardiol; 1985 Apr; 74(4):205-12. PubMed ID: 3923726 [TBL] [Abstract][Full Text] [Related]
29. [Sustained and beneficial hemodynamic effects of prazosin in cardiac insufficiency]. Harrison DC; Feldman RC; Ball RM Cardiology; 1980; 66 Suppl 2():162-8. PubMed ID: 6456814 [No Abstract] [Full Text] [Related]
30. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy. Awan NA; Lee G; DeMaria AN; Mason DT Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594 [TBL] [Abstract][Full Text] [Related]
31. Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease. Silke B; Nelson GI; Ahuja RC; Taylor SH Br Heart J; 1982 Oct; 48(4):364-71. PubMed ID: 7126388 [TBL] [Abstract][Full Text] [Related]
32. Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin. Bayliss J; Norell MS; Canepa-Anson R; Reid C; Poole-Wilson P; Sutton G Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1861-5. PubMed ID: 3924285 [TBL] [Abstract][Full Text] [Related]
33. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure. Mehta J; Iacona M; Pepine CJ; Conti CR Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583 [TBL] [Abstract][Full Text] [Related]
34. Initial and long-term effects of prazosin on sympathetic vasopressor responses in essential hypertension. Khatri IM; Levinson P; Notargiacomo A; Freis ED Am J Cardiol; 1985 Apr; 55(8):1015-8. PubMed ID: 3984860 [TBL] [Abstract][Full Text] [Related]
35. [Variable acute effects of prazosin on left ventricular failure (author's transl)]. Hepp A; Schick KD; Larbig D; Haasis R; Liebau G; Riegger G; Kochsiek K Dtsch Med Wochenschr; 1980 Nov; 105(47):1647-50. PubMed ID: 7439046 [TBL] [Abstract][Full Text] [Related]
36. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combination of beta-receptor blocking and vasodilator agent. Koch G Br Heart J; 1976 Dec; 38(12):1240-6. PubMed ID: 1008968 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular consequences of primary antihypertensive therapy with prazosin hydrochloride. Scharf SC; Lee HB; Wexler JP; Blaufox MD Am J Cardiol; 1984 Jan; 53(3):32A-36A. PubMed ID: 6364759 [TBL] [Abstract][Full Text] [Related]
38. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)]. Sparvieri F; Cesari GP; Soro A G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400 [TBL] [Abstract][Full Text] [Related]
39. Effect of prazosin vs placebo on chronic left ventricular heart failure. Aronow WS; Lurie M; Turbow M; Whittaker K; Van Camp S; Hughes D Circulation; 1979 Feb; 59(2):344-50. PubMed ID: 365391 [TBL] [Abstract][Full Text] [Related]
40. Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise. Higginbotham MB; Morris KG; Bramlet DA; Coleman RE; Cobb FR Am J Cardiol; 1983 Oct; 52(7):782-8. PubMed ID: 6353898 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]